Author Archives: Scalper1

Pfizer, Allergan Near Deal As Tax Inversion Rules Loom

Pfizer (PFE) is near a massive deal to buy Allergan (AGN) and redomicile in Ireland, multiple reports said, even as the Treasury Department plans to impose new restrictions on tax inversions. Pfizer are discussing a deal that would pay $370-$380 a share for Botox maker Allergan, Bloomberg and Reuters reported late Wednesday. Allergan rose 4.5% to 310.83 on Wednesday, but retreated after hours following news of the inversion rules. Allergan traded

Square Prices IPO Below Expected Range, Match Weak

Mobile payments company Square (SQ) late Wednesday priced its initial public offering at $9 a share, well below the expected range of $11 to $13. Meanwhile, online dating site operator Match Group (MTCH) priced at the low end of its expected range Square will begin trading Thursday under the ticker SQ on the New York Stock Exchange. The company sold 27 million shares, raising $243 million. The IPO pricing for Square values the company at $2.66

Alphabet Inc Killing Chrome: Is This a Greater Threat to Apple Inc or Microsoft Corporation?

Source Alphabet Google We tend to overestimate the effect of a technology in the short run and underestimate the effect in the long run. Roy Amara